Trivascular
AcquiredSanta Rosa, US · Founded 2007 · Delaware corporation · 2 known investors
Find your way into Trivascular
57 people in our graph share verified history with the Trivascular team — schools, employers, funds. One of them is your warm intro.
Hal Pazunlockedknows VIVEK K. JAYARAMAN · together at Johnson & Johnson (overlapped)
×8knows the team · via Johnson & Johnson
×2knows the team · via ONWARD Medical
knows the team · via Trivascular
Founders & leadership
Trivascular was founded in 2007 by Michael V. Chobotov.
MV
Michael V. ChobotovinChief Technology Officer, Board of Directors, Co-founder2012–2016Michael Chobotov is an executive with experience in medical device, aerospace, and automotive sectors, holding more than 60 US patents. He has worked across medical devices, engineering, and early-stage ventures.
SL
SHARI L. O'QUINNinVice President, Clinical & Regulatory2016–2017Shari L. O'Quinn is an executive officer at Trivascular with experience leading clinical, regulatory, quality, medical affairs, and health economics functions across multiple regions including the U.S., EMEA, LATAM, and APAC in the medical technology sector.
MR
Michael R. KramerExecutive
KE
KIMBERLEY ELTINGExecutive
CC
CHRISTOPHER CHAVEZExecutive
VK
VIVEK K. JAYARAMANinConsultant2016–2016Vivek K. Jayaraman is an executive with experience in healthcare marketing, sales, operations, product management, and business development across pharmaceutical, biotechnology, and medical device sectors. He has held management roles in sales, marketing, and R&D, worked in Asia, and has a background in management consulting advising healthcare companies.
Board
DA
Douglas A. RoederBoard director
RD
Ryan D. DrantBoard director
RW
Robert W. ThomasBoard director
JP
James P. ScopaBoard director
JR
JS
James ShapiroBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$17.2M disclosed across 2 rounds · 2012–2015
▶$10MraisedAug 2015 · 5 investors · Other Health CareRule 506(b)
▶$10MraisedAug 2015 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- DOUGLAS A. ROEDERDirector
- SHARI L. O'QUINNExecutive Officer
- MICHAEL V. CHOBOTOVExecutive Officer
- MICHAEL R. KRAMERExecutive Officer
- RYAN D. DRANTDirector
- DANIEL J. MOOREDirector
- KIMBERLEY ELTINGExecutive Officer
- CHRISTOPHER CHAVEZExecutive Officer, Director
- ROBERT W. THOMASDirector
- VIVEK K. JAYARAMANExecutive Officer
- JAMES P. SCOPADirector
- JAKE R. NUNNDirector
- Offering amount
- $10M
- Amount sold
- $10M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.2MraisedFeb 2012 · 22 investors · Other Health CareRule 506(b)
▶$7.2MraisedFeb 2012 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Douglas RoederDirector
- Michael KramerExecutive Officer
- Jake NunnDirector
- James ShapiroDirector
- David KimDirector
- Michael ChobotovExecutive Officer, Director
- James ScopaDirector
- Ryan DrantDirector
- DANIEL MOOREDirector
- Robert ThomasExecutive Officer, Director
- Offering amount
- $7.2M
- Amount sold
- $7.2M
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Trivascular?
- Trivascular was founded by Michael V. Chobotov in 2007.
- Who are Trivascular's investors?
- Trivascular's investors include Kaiser Permanente Ventures, SR One Capital Management.
- How much funding has Trivascular raised?
- Trivascular has disclosed $17.2M raised across 2 rounds.
- Where is Trivascular headquartered?
- Trivascular is headquartered in Santa Rosa, US.